These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8603403)

  • 1. Second malignant neoplasms among long-term survivors of ovarian cancer.
    Travis LB; Curtis RE; Boice JD; Platz CE; Hankey BF; Fraumeni JF
    Cancer Res; 1996 Apr; 56(7):1564-70. PubMed ID: 8603403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second primary ovarian cancer among women diagnosed previously with cancer.
    Hall HI; Jamison P; Weir HK
    Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):995-9. PubMed ID: 11535553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A population-based study of subsequent primary malignancies after endometrial cancer: genetic, environmental, and treatment-related associations.
    Brown AP; Neeley ES; Werner T; Soisson AP; Burt RW; Gaffney DK
    Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):127-35. PubMed ID: 19910129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
    Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE
    J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The risk of developing second cancers among survivors of childhood soft tissue sarcoma.
    Cohen RJ; Curtis RE; Inskip PD; Fraumeni JF
    Cancer; 2005 Jun; 103(11):2391-6. PubMed ID: 15852362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer risk factors and second primary malignancies among women with breast cancer.
    Trentham-Dietz A; Newcomb PA; Nichols HB; Hampton JM
    Breast Cancer Res Treat; 2007 Oct; 105(2):195-207. PubMed ID: 17186360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up.
    Liauw SL; Sylvester JE; Morris CG; Blasko JC; Grimm PD
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):669-73. PubMed ID: 16887293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second cancer following cancer of the female genital system in Connecticut, 1935-82.
    Curtis RE; Hoover RN; Kleinerman RA; Harvey EB
    Natl Cancer Inst Monogr; 1985 Dec; 68():113-37. PubMed ID: 4088293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of a second malignant neoplasm among 5-year survivors of cancer in childhood and adolescence in British Columbia, Canada.
    MacArthur AC; Spinelli JJ; Rogers PC; Goddard KJ; Phillips N; McBride ML
    Pediatr Blood Cancer; 2007 Apr; 48(4):453-9. PubMed ID: 16767718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased risk of second cancer among patients with ovarian borderline tumors.
    Bouchardy C; Fernandez S; Merglen A; Usel M; Fioretta G; Rapiti E; Schubert H; Pelte MF; Chappuis PO; Vlastos G
    Gynecol Oncol; 2008 May; 109(2):210-4. PubMed ID: 18377966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second neoplasms after invasive and borderline ovarian cancer.
    Levi F; Randimbison L; Blanc-Moya R; La Vecchia C
    Eur J Cancer Prev; 2009 Jun; 18(3):216-9. PubMed ID: 19491608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study.
    Schaapveld M; Visser O; Louwman MJ; de Vries EG; Willemse PH; Otter R; van der Graaf WT; Coebergh JW; van Leeuwen FE
    J Clin Oncol; 2008 Mar; 26(8):1239-46. PubMed ID: 18323547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salivary gland cancer in the United States.
    Sun EC; Curtis R; Melbye M; Goedert JJ
    Cancer Epidemiol Biomarkers Prev; 1999 Dec; 8(12):1095-100. PubMed ID: 10613342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second primary cancers in men with prostate cancer: an increased risk of male breast cancer.
    Thellenberg C; Malmer B; Tavelin B; Grönberg H
    J Urol; 2003 Apr; 169(4):1345-8. PubMed ID: 12629357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma.
    Tward JD; Wendland MM; Shrieve DC; Szabo A; Gaffney DK
    Cancer; 2006 Jul; 107(1):108-15. PubMed ID: 16708354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excess risk of subsequent primary cancers among colorectal carcinoma survivors, 1975-2001.
    Ahmed F; Goodman MT; Kosary C; Ruiz B; Wu XC; Chen VW; Correa CN
    Cancer; 2006 Sep; 107(5 Suppl):1162-71. PubMed ID: 16838312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second cancer following cancer of the breast in Connecticut, 1935-82.
    Harvey EB; Brinton LA
    Natl Cancer Inst Monogr; 1985 Dec; 68():99-112. PubMed ID: 4088315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second cancer following cancer of the digestive system in Connecticut, 1935-82.
    Hoar SK; Wilson J; Blot WJ; McLaughlin JK; Winn DM; Kantor AF
    Natl Cancer Inst Monogr; 1985 Dec; 68():49-82. PubMed ID: 4088313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study.
    Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Tracey E; Sankila R; Weiderpass E; Olsen JH; McBride ML; Brewster DH; Pompe-Kirn V; Kliewer EV; Chia KS; Tonita JM; Martos C; Jonasson JG; Merletti F; Boffetta P
    J Natl Cancer Inst; 2007 May; 99(10):790-800. PubMed ID: 17505074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.